SCHEMBL6209447

SCHEMBL6209447

CC(CCNC(=O)OCc1ccccc1)CC(=O)N1CCC2C1C(=O)CN2S(=O)(=O)c1cccnc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
LMNA P02545 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
TP53 P04637 1/20 0.38
GFER P55789 1/20 0.38
TSHR P16473 1/20 0.37
NAMPT P43490 1/20 0.37
GAA P10253 1/20 0.37
CTSB P07858 1/20 0.36
CTSS P25774 1/20 0.36
CTSK P43235 1/20 0.36
KCNA5 P22460 2/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
GRIN2B Q13224 1/20 0.36
HSD17B10 Q99714 1/20 0.36
MMP3 P08254 3/20 0.36
MMP9 P14780 3/20 0.36
MMP2 P08253 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6211014 0.91 CTSB (0.39) LMNASMN1; SMN2TP53GFERGAA
SCHEMBL6254282 0.87 CTSK (0.38) GAACTSSCTSKKCNA5KEAP1
SCHEMBL6212092 0.87 PREP (0.48) ALDH1A1LMNASMN1; SMN2TP53GFER
SCHEMBL6211554 0.86 KCNA5 (0.39) ALDH1A1LMNASMN1; SMN2TP53GFER
SCHEMBL6211220 0.84 CHRM4 (0.38) ALDH1A1LMNATP53HSD17B10MMP2
SCHEMBL6210847 0.84 KEAP1 (0.38) ALDH1A1SMN1; SMN2TSHRGAAKCNA5
SCHEMBL6213622 0.83 LMNA (0.38) ALDH1A1LMNASMN1; SMN2TSHRNAMPT
SCHEMBL6209651 0.83 LMNA (0.42) LMNATP53NAMPTGAAMMP3
SCHEMBL6212436 0.83 LMNA (0.38) ALDH1A1LMNATSHRHSD17B10ELOVL6
SCHEMBL6211558 0.83 LMNA (0.38) ALDH1A1LMNATSHRHSD17B10ELOVL6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546150-A1 BIOLOGICALLY ACTIVE COMPOUNDS Amura Therapeutics Limited (GB) 2005-06-29 EP disclosed
WO-2004007501-A1 BIOLOGICALLY ACTIVE COMPOUNDS AMURA THERAPEUTICS LIMITED (GB) 2004-01-22 WO disclosed